(2004). Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives. Atherosclerosis, 5(3), 263272. 15. Goldberg, R. J., & Katz, J. (2007). A metaanalysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain, 129(1-2), 210-223. 16.Martins, J. G. (2009). EPA but not DHA appears to be responsible for the efficacy of omega-3 long-chain polyunsaturated fatty acid supplementation in depression. Journal of the American College of Nutrition, 28(5), 525-542. 17. Calder, P. C. (2013). Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? British Journal of Clinical Pharmacology, 75(3), 645-662. 18. Colombo, J., et al. (2017). Long-term effects of LCPUFA supplementation on childhood cognitive outcomes. The American Journal of Clinical Nutrition, 106(6), 1457-1463. 19. Grosso, G., et al. (2014). Role of omega-3 fatty acids in the treatment of depressive disorders. PLoS One, 9(5), e96905. 20.European Food Safety Authority (EFSA). (2012). Scientific opinion on the tolerable upper intake level of EPA, DHA and the combination of both. EFSA Journal, 10(7), 2815. Kapitola: asté dotazy o Omega-3 800 182 572 7:30-16:30 (Pá: do14:00) Vyhlídka 39, 63800 Brno, eská republika Tel: +420 545 222 863 Fax: +420 545 222 011 www.vitaminy-mineraly.cz Strana 64 V I
RkJQdWJsaXNoZXIy Nzg5MDg=